MSP Recovery, Inc. (NASDAQ: MSPR) Stock Competitors & Peer Comparison
See MSPR's competitors and their performance on the NASDAQ and across the wider stock market.
Peer Comparison Table: Medical - Healthcare Information Services Industry
Detailed financial metrics including price, market cap, P/E ratio, and more for MSPR and its NASDAQ peers.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| MSPR | $0.00 | +0.00% | 1.4K | N/A | -$2,345.39 | N/A |
| GEHCV | $56.00 | -4.08% | 25.5B | N/A | N/A | N/A |
| TEM | $84.44 | +11.03% | 15B | -168.82 | -$0.50 | N/A |
| BTSG | $69.15 | +2.98% | 13.8B | 40.44 | $1.71 | N/A |
| BTSGU | $227.64 | +7.33% | 13.7B | 133.04 | $1.71 | N/A |
| HNGE | $122.19 | +5.55% | 9.9B | 65.34 | $1.87 | N/A |
| SGFY | $30.49 | +0.07% | 8.9B | 70.91 | $0.43 | N/A |
| HQY | $102.11 | -1.47% | 8.4B | 23.86 | $4.28 | N/A |
| RCM | $14.31 | N/A | 6B | -102.21 | -$0.14 | N/A |
| DOCS | $32.87 | +1.11% | 5.9B | 21.48 | $1.53 | N/A |
Stock Comparison
GE HealthCare Technologies Inc. (NASDAQ: GEHCV)
MSPR vs GEHCV Comparison November 2026
MSP Recovery, Inc. (NASDAQ: MSPR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MSPR stands at 1.4K. In comparison, GEHCV has a market cap of 25.5B. Regarding current trading prices, MSPR is priced at $0.00 on the NASDAQ, while GEHCV trades at $56.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MSPR currently has a P/E ratio of N/A, whereas GEHCV's P/E ratio is N/A. In terms of profitability, MSPR's ROE is N/A, compared to GEHCV's ROE of +0.20%. Regarding short-term risk, MSPR is more volatile compared to GEHCV. This indicates higher risk in terms of short-term price fluctuations for MSPR.Check GEHCV's competition here
Tempus AI, Inc. (NASDAQ: TEM)
MSPR vs TEM Comparison November 2026
MSP Recovery, Inc. (NASDAQ: MSPR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MSPR stands at 1.4K. In comparison, TEM has a market cap of 15B. Regarding current trading prices, MSPR is priced at $0.00 on the NASDAQ, while TEM trades at $84.44.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MSPR currently has a P/E ratio of N/A, whereas TEM's P/E ratio is -168.82. In terms of profitability, MSPR's ROE is N/A, compared to TEM's ROE of -0.41%. Regarding short-term risk, MSPR is more volatile compared to TEM. This indicates higher risk in terms of short-term price fluctuations for MSPR.Check TEM's competition here
BrightSpring Health Services, Inc. Common Stock (NASDAQ: BTSG)
MSPR vs BTSG Comparison November 2026
MSP Recovery, Inc. (NASDAQ: MSPR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MSPR stands at 1.4K. In comparison, BTSG has a market cap of 13.8B. Regarding current trading prices, MSPR is priced at $0.00 on the NASDAQ, while BTSG trades at $69.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MSPR currently has a P/E ratio of N/A, whereas BTSG's P/E ratio is 40.44. In terms of profitability, MSPR's ROE is N/A, compared to BTSG's ROE of +0.17%. Regarding short-term risk, MSPR is more volatile compared to BTSG. This indicates higher risk in terms of short-term price fluctuations for MSPR.Check BTSG's competition here
BrightSpring Health Services, Inc. Tangible Equity Unit (NASDAQ: BTSGU)
MSPR vs BTSGU Comparison November 2026
MSP Recovery, Inc. (NASDAQ: MSPR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MSPR stands at 1.4K. In comparison, BTSGU has a market cap of 13.7B. Regarding current trading prices, MSPR is priced at $0.00 on the NASDAQ, while BTSGU trades at $227.64.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MSPR currently has a P/E ratio of N/A, whereas BTSGU's P/E ratio is 133.04. In terms of profitability, MSPR's ROE is N/A, compared to BTSGU's ROE of +0.17%. Regarding short-term risk, MSPR is more volatile compared to BTSGU. This indicates higher risk in terms of short-term price fluctuations for MSPR.Check BTSGU's competition here
Hinge Health, Inc. (NYSE: HNGE)
MSPR vs HNGE Comparison November 2026
MSP Recovery, Inc. (NASDAQ: MSPR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MSPR stands at 1.4K. In comparison, HNGE has a market cap of 9.9B. Regarding current trading prices, MSPR is priced at $0.00 on the NASDAQ, while HNGE trades at $122.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MSPR currently has a P/E ratio of N/A, whereas HNGE's P/E ratio is 65.34. In terms of profitability, MSPR's ROE is N/A, compared to HNGE's ROE of +0.50%. Regarding short-term risk, MSPR is more volatile compared to HNGE. This indicates higher risk in terms of short-term price fluctuations for MSPR.Check HNGE's competition here
Signify Health, Inc. (NYSE: SGFY)
MSPR vs SGFY Comparison November 2026
MSP Recovery, Inc. (NASDAQ: MSPR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MSPR stands at 1.4K. In comparison, SGFY has a market cap of 8.9B. Regarding current trading prices, MSPR is priced at $0.00 on the NASDAQ, while SGFY trades at $30.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MSPR currently has a P/E ratio of N/A, whereas SGFY's P/E ratio is 70.91. In terms of profitability, MSPR's ROE is N/A, compared to SGFY's ROE of -0.15%. Regarding short-term risk, MSPR is more volatile compared to SGFY. This indicates higher risk in terms of short-term price fluctuations for MSPR.Check SGFY's competition here
HealthEquity, Inc. (NASDAQ: HQY)
MSPR vs HQY Comparison November 2026
MSP Recovery, Inc. (NASDAQ: MSPR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MSPR stands at 1.4K. In comparison, HQY has a market cap of 8.4B. Regarding current trading prices, MSPR is priced at $0.00 on the NASDAQ, while HQY trades at $102.11.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MSPR currently has a P/E ratio of N/A, whereas HQY's P/E ratio is 23.86. In terms of profitability, MSPR's ROE is N/A, compared to HQY's ROE of +0.11%. Regarding short-term risk, MSPR is more volatile compared to HQY. This indicates higher risk in terms of short-term price fluctuations for MSPR.Check HQY's competition here
R1 RCM Inc. (NASDAQ: RCM)
MSPR vs RCM Comparison November 2026
MSP Recovery, Inc. (NASDAQ: MSPR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MSPR stands at 1.4K. In comparison, RCM has a market cap of 6B. Regarding current trading prices, MSPR is priced at $0.00 on the NASDAQ, while RCM trades at $14.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MSPR currently has a P/E ratio of N/A, whereas RCM's P/E ratio is -102.21. In terms of profitability, MSPR's ROE is N/A, compared to RCM's ROE of +0.00%. Regarding short-term risk, MSPR is more volatile compared to RCM. This indicates higher risk in terms of short-term price fluctuations for MSPR.Check RCM's competition here
Doximity, Inc. (NYSE: DOCS)
MSPR vs DOCS Comparison November 2026
MSP Recovery, Inc. (NASDAQ: MSPR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MSPR stands at 1.4K. In comparison, DOCS has a market cap of 5.9B. Regarding current trading prices, MSPR is priced at $0.00 on the NASDAQ, while DOCS trades at $32.87.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MSPR currently has a P/E ratio of N/A, whereas DOCS's P/E ratio is 21.48. In terms of profitability, MSPR's ROE is N/A, compared to DOCS's ROE of +0.15%. Regarding short-term risk, MSPR is more volatile compared to DOCS. This indicates higher risk in terms of short-term price fluctuations for MSPR.Check DOCS's competition here
Waystar Holding Corp. (NASDAQ: WAY)
MSPR vs WAY Comparison November 2026
MSP Recovery, Inc. (NASDAQ: MSPR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MSPR stands at 1.4K. In comparison, WAY has a market cap of 5.6B. Regarding current trading prices, MSPR is priced at $0.00 on the NASDAQ, while WAY trades at $29.18.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MSPR currently has a P/E ratio of N/A, whereas WAY's P/E ratio is 19.33. In terms of profitability, MSPR's ROE is N/A, compared to WAY's ROE of +0.03%. Regarding short-term risk, MSPR is more volatile compared to WAY. This indicates higher risk in terms of short-term price fluctuations for MSPR.Check WAY's competition here
Heartflow, Inc. Common Stock (NASDAQ: HTFL)
MSPR vs HTFL Comparison November 2026
MSP Recovery, Inc. (NASDAQ: MSPR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MSPR stands at 1.4K. In comparison, HTFL has a market cap of 4.9B. Regarding current trading prices, MSPR is priced at $0.00 on the NASDAQ, while HTFL trades at $56.66.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MSPR currently has a P/E ratio of N/A, whereas HTFL's P/E ratio is -28.19. In terms of profitability, MSPR's ROE is N/A, compared to HTFL's ROE of -0.42%. Regarding short-term risk, MSPR is more volatile compared to HTFL. This indicates higher risk in terms of short-term price fluctuations for MSPR.Check HTFL's competition here
1Life Healthcare, Inc. (NASDAQ: ONEM)
MSPR vs ONEM Comparison November 2026
MSP Recovery, Inc. (NASDAQ: MSPR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MSPR stands at 1.4K. In comparison, ONEM has a market cap of 3.4B. Regarding current trading prices, MSPR is priced at $0.00 on the NASDAQ, while ONEM trades at $16.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MSPR currently has a P/E ratio of N/A, whereas ONEM's P/E ratio is -7.77. In terms of profitability, MSPR's ROE is N/A, compared to ONEM's ROE of -0.24%. Regarding short-term risk, MSPR is more volatile compared to ONEM. This indicates higher risk in terms of short-term price fluctuations for MSPR.Check ONEM's competition here
Privia Health Group, Inc. (NASDAQ: PRVA)
MSPR vs PRVA Comparison November 2026
MSP Recovery, Inc. (NASDAQ: MSPR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MSPR stands at 1.4K. In comparison, PRVA has a market cap of 3.1B. Regarding current trading prices, MSPR is priced at $0.00 on the NASDAQ, while PRVA trades at $24.54.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MSPR currently has a P/E ratio of N/A, whereas PRVA's P/E ratio is 116.95. In terms of profitability, MSPR's ROE is N/A, compared to PRVA's ROE of +0.05%. Regarding short-term risk, MSPR is more volatile compared to PRVA. This indicates higher risk in terms of short-term price fluctuations for MSPR.Check PRVA's competition here
Certara, Inc. (NASDAQ: CERT)
MSPR vs CERT Comparison November 2026
MSP Recovery, Inc. (NASDAQ: MSPR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MSPR stands at 1.4K. In comparison, CERT has a market cap of 1.9B. Regarding current trading prices, MSPR is priced at $0.00 on the NASDAQ, while CERT trades at $12.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MSPR currently has a P/E ratio of N/A, whereas CERT's P/E ratio is 30.53. In terms of profitability, MSPR's ROE is N/A, compared to CERT's ROE of -0.06%. Regarding short-term risk, MSPR is more volatile compared to CERT. This indicates higher risk in terms of short-term price fluctuations for MSPR.Check CERT's competition here
Omnicell, Inc. (NASDAQ: OMCL)
MSPR vs OMCL Comparison November 2026
MSP Recovery, Inc. (NASDAQ: MSPR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MSPR stands at 1.4K. In comparison, OMCL has a market cap of 1.7B. Regarding current trading prices, MSPR is priced at $0.00 on the NASDAQ, while OMCL trades at $37.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MSPR currently has a P/E ratio of N/A, whereas OMCL's P/E ratio is 19.55. In terms of profitability, MSPR's ROE is N/A, compared to OMCL's ROE of +0.04%. Regarding short-term risk, MSPR is more volatile compared to OMCL. This indicates higher risk in terms of short-term price fluctuations for MSPR.Check OMCL's competition here
Teladoc Health, Inc. (NYSE: TDOC)
MSPR vs TDOC Comparison November 2026
MSP Recovery, Inc. (NASDAQ: MSPR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MSPR stands at 1.4K. In comparison, TDOC has a market cap of 1.6B. Regarding current trading prices, MSPR is priced at $0.00 on the NASDAQ, while TDOC trades at $8.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MSPR currently has a P/E ratio of N/A, whereas TDOC's P/E ratio is -10.44. In terms of profitability, MSPR's ROE is N/A, compared to TDOC's ROE of -0.12%. Regarding short-term risk, MSPR is more volatile compared to TDOC. This indicates higher risk in terms of short-term price fluctuations for MSPR.Check TDOC's competition here
NextGen Healthcare, Inc. (NASDAQ: NXGN)
MSPR vs NXGN Comparison November 2026
MSP Recovery, Inc. (NASDAQ: MSPR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MSPR stands at 1.4K. In comparison, NXGN has a market cap of 1.6B. Regarding current trading prices, MSPR is priced at $0.00 on the NASDAQ, while NXGN trades at $23.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MSPR currently has a P/E ratio of N/A, whereas NXGN's P/E ratio is -266.00. In terms of profitability, MSPR's ROE is N/A, compared to NXGN's ROE of -0.01%. Regarding short-term risk, MSPR is more volatile compared to NXGN. This indicates higher risk in terms of short-term price fluctuations for MSPR.Check NXGN's competition here
Agiliti, Inc. (NYSE: AGTI)
MSPR vs AGTI Comparison November 2026
MSP Recovery, Inc. (NASDAQ: MSPR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MSPR stands at 1.4K. In comparison, AGTI has a market cap of 1.4B. Regarding current trading prices, MSPR is priced at $0.00 on the NASDAQ, while AGTI trades at $10.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MSPR currently has a P/E ratio of N/A, whereas AGTI's P/E ratio is -71.79. In terms of profitability, MSPR's ROE is N/A, compared to AGTI's ROE of -0.02%. Regarding short-term risk, MSPR is more volatile compared to AGTI. This indicates higher risk in terms of short-term price fluctuations for MSPR.Check AGTI's competition here
GoodRx Holdings, Inc. (NASDAQ: GDRX)
MSPR vs GDRX Comparison November 2026
MSP Recovery, Inc. (NASDAQ: MSPR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MSPR stands at 1.4K. In comparison, GDRX has a market cap of 1.2B. Regarding current trading prices, MSPR is priced at $0.00 on the NASDAQ, while GDRX trades at $3.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MSPR currently has a P/E ratio of N/A, whereas GDRX's P/E ratio is 11.41. In terms of profitability, MSPR's ROE is N/A, compared to GDRX's ROE of +0.03%. Regarding short-term risk, MSPR is more volatile compared to GDRX. This indicates higher risk in terms of short-term price fluctuations for MSPR.Check GDRX's competition here
Omada Health (NASDAQ: OMDA)
MSPR vs OMDA Comparison November 2026
MSP Recovery, Inc. (NASDAQ: MSPR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MSPR stands at 1.4K. In comparison, OMDA has a market cap of 923.1M. Regarding current trading prices, MSPR is priced at $0.00 on the NASDAQ, while OMDA trades at $15.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MSPR currently has a P/E ratio of N/A, whereas OMDA's P/E ratio is 65.57. In terms of profitability, MSPR's ROE is N/A, compared to OMDA's ROE of +0.02%. Regarding short-term risk, MSPR is more volatile compared to OMDA. This indicates higher risk in terms of short-term price fluctuations for MSPR.Check OMDA's competition here
HealthStream, Inc. (NASDAQ: HSTM)
MSPR vs HSTM Comparison November 2026
MSP Recovery, Inc. (NASDAQ: MSPR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MSPR stands at 1.4K. In comparison, HSTM has a market cap of 882.1M. Regarding current trading prices, MSPR is priced at $0.00 on the NASDAQ, while HSTM trades at $28.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MSPR currently has a P/E ratio of N/A, whereas HSTM's P/E ratio is 40.04. In terms of profitability, MSPR's ROE is N/A, compared to HSTM's ROE of +0.06%. Regarding short-term risk, MSPR is more volatile compared to HSTM. This indicates higher risk in terms of short-term price fluctuations for MSPR.Check HSTM's competition here
CareCloud, Inc. (NASDAQ: CCLDO)
MSPR vs CCLDO Comparison November 2026
MSP Recovery, Inc. (NASDAQ: MSPR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MSPR stands at 1.4K. In comparison, CCLDO has a market cap of 857.3M. Regarding current trading prices, MSPR is priced at $0.00 on the NASDAQ, while CCLDO trades at $27.44.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MSPR currently has a P/E ratio of N/A, whereas CCLDO's P/E ratio is N/A. In terms of profitability, MSPR's ROE is N/A, compared to CCLDO's ROE of +0.24%. Regarding short-term risk, MSPR is more volatile compared to CCLDO. This indicates higher risk in terms of short-term price fluctuations for MSPR.Check CCLDO's competition here
Phreesia, Inc. (NYSE: PHR)
MSPR vs PHR Comparison November 2026
MSP Recovery, Inc. (NASDAQ: MSPR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MSPR stands at 1.4K. In comparison, PHR has a market cap of 800.7M. Regarding current trading prices, MSPR is priced at $0.00 on the NASDAQ, while PHR trades at $12.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MSPR currently has a P/E ratio of N/A, whereas PHR's P/E ratio is 46.07. In terms of profitability, MSPR's ROE is N/A, compared to PHR's ROE of +0.03%. Regarding short-term risk, MSPR is more volatile compared to PHR. This indicates higher risk in terms of short-term price fluctuations for MSPR.Check PHR's competition here
SOPHiA GENETICS S.A. (NASDAQ: SOPH)
MSPR vs SOPH Comparison November 2026
MSP Recovery, Inc. (NASDAQ: MSPR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MSPR stands at 1.4K. In comparison, SOPH has a market cap of 636.8M. Regarding current trading prices, MSPR is priced at $0.00 on the NASDAQ, while SOPH trades at $7.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MSPR currently has a P/E ratio of N/A, whereas SOPH's P/E ratio is -6.74. In terms of profitability, MSPR's ROE is N/A, compared to SOPH's ROE of -1.33%. Regarding short-term risk, MSPR is more volatile compared to SOPH. This indicates higher risk in terms of short-term price fluctuations for MSPR.Check SOPH's competition here
MultiPlan Corporation (NYSE: MPLN-WT)
MSPR vs MPLN-WT Comparison November 2026
MSP Recovery, Inc. (NASDAQ: MSPR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MSPR stands at 1.4K. In comparison, MPLN-WT has a market cap of 625.2M. Regarding current trading prices, MSPR is priced at $0.00 on the NASDAQ, while MPLN-WT trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MSPR currently has a P/E ratio of N/A, whereas MPLN-WT's P/E ratio is N/A. In terms of profitability, MSPR's ROE is N/A, compared to MPLN-WT's ROE of +1.40%. Regarding short-term risk, MSPR is more volatile compared to MPLN-WT. This indicates higher risk in terms of short-term price fluctuations for MSPR.Check MPLN-WT's competition here
NRC Health (NASDAQ: NRC)
MSPR vs NRC Comparison November 2026
MSP Recovery, Inc. (NASDAQ: MSPR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MSPR stands at 1.4K. In comparison, NRC has a market cap of 588.6M. Regarding current trading prices, MSPR is priced at $0.00 on the NASDAQ, while NRC trades at $26.67.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MSPR currently has a P/E ratio of N/A, whereas NRC's P/E ratio is 32.45. In terms of profitability, MSPR's ROE is N/A, compared to NRC's ROE of +1.03%. Regarding short-term risk, MSPR is more volatile compared to NRC. This indicates higher risk in terms of short-term price fluctuations for MSPR.Check NRC's competition here
Accolade, Inc. (NASDAQ: ACCD)
MSPR vs ACCD Comparison November 2026
MSP Recovery, Inc. (NASDAQ: MSPR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MSPR stands at 1.4K. In comparison, ACCD has a market cap of 575.6M. Regarding current trading prices, MSPR is priced at $0.00 on the NASDAQ, while ACCD trades at $7.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MSPR currently has a P/E ratio of N/A, whereas ACCD's P/E ratio is -3.08. In terms of profitability, MSPR's ROE is N/A, compared to ACCD's ROE of -0.22%. Regarding short-term risk, MSPR is more volatile compared to ACCD. This indicates higher risk in terms of short-term price fluctuations for MSPR.Check ACCD's competition here
Sharecare, Inc. (NASDAQ: SHCR)
MSPR vs SHCR Comparison November 2026
MSP Recovery, Inc. (NASDAQ: MSPR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MSPR stands at 1.4K. In comparison, SHCR has a market cap of 531.8M. Regarding current trading prices, MSPR is priced at $0.00 on the NASDAQ, while SHCR trades at $1.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MSPR currently has a P/E ratio of N/A, whereas SHCR's P/E ratio is -3.76. In terms of profitability, MSPR's ROE is N/A, compared to SHCR's ROE of -0.25%. Regarding short-term risk, MSPR is more volatile compared to SHCR. This indicates higher risk in terms of short-term price fluctuations for MSPR.Check SHCR's competition here
Evolent Health, Inc. (NYSE: EVH)
MSPR vs EVH Comparison November 2026
MSP Recovery, Inc. (NASDAQ: MSPR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MSPR stands at 1.4K. In comparison, EVH has a market cap of 529.2M. Regarding current trading prices, MSPR is priced at $0.00 on the NASDAQ, while EVH trades at $4.71.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MSPR currently has a P/E ratio of N/A, whereas EVH's P/E ratio is 36.19. In terms of profitability, MSPR's ROE is N/A, compared to EVH's ROE of -1.30%. Regarding short-term risk, MSPR is more volatile compared to EVH. This indicates higher risk in terms of short-term price fluctuations for MSPR.Check EVH's competition here
Carlsmed, Inc. (NASDAQ: CARL)
MSPR vs CARL Comparison November 2026
MSP Recovery, Inc. (NASDAQ: MSPR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MSPR stands at 1.4K. In comparison, CARL has a market cap of 438.2M. Regarding current trading prices, MSPR is priced at $0.00 on the NASDAQ, while CARL trades at $16.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MSPR currently has a P/E ratio of N/A, whereas CARL's P/E ratio is -11.22. In terms of profitability, MSPR's ROE is N/A, compared to CARL's ROE of -0.38%. Regarding short-term risk, MSPR is more volatile compared to CARL. This indicates higher risk in terms of short-term price fluctuations for MSPR.Check CARL's competition here
Claritev Corporation (NYSE: CTEV)
MSPR vs CTEV Comparison November 2026
MSP Recovery, Inc. (NASDAQ: MSPR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MSPR stands at 1.4K. In comparison, CTEV has a market cap of 407.8M. Regarding current trading prices, MSPR is priced at $0.00 on the NASDAQ, while CTEV trades at $24.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MSPR currently has a P/E ratio of N/A, whereas CTEV's P/E ratio is -1.41. In terms of profitability, MSPR's ROE is N/A, compared to CTEV's ROE of +1.40%. Regarding short-term risk, MSPR is more volatile compared to CTEV. This indicates higher risk in terms of short-term price fluctuations for MSPR.Check CTEV's competition here
SomaLogic, Inc. (NASDAQ: SLGC)
MSPR vs SLGC Comparison November 2026
MSP Recovery, Inc. (NASDAQ: MSPR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MSPR stands at 1.4K. In comparison, SLGC has a market cap of 396.2M. Regarding current trading prices, MSPR is priced at $0.00 on the NASDAQ, while SLGC trades at $2.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MSPR currently has a P/E ratio of N/A, whereas SLGC's P/E ratio is -3.04. In terms of profitability, MSPR's ROE is N/A, compared to SLGC's ROE of -0.19%. Regarding short-term risk, MSPR is more volatile compared to SLGC. This indicates higher risk in terms of short-term price fluctuations for MSPR.Check SLGC's competition here
SomaLogic, Inc. (NASDAQ: SLGCW)
MSPR vs SLGCW Comparison November 2026
MSP Recovery, Inc. (NASDAQ: MSPR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MSPR stands at 1.4K. In comparison, SLGCW has a market cap of 396.2M. Regarding current trading prices, MSPR is priced at $0.00 on the NASDAQ, while SLGCW trades at $0.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MSPR currently has a P/E ratio of N/A, whereas SLGCW's P/E ratio is -0.16. In terms of profitability, MSPR's ROE is N/A, compared to SLGCW's ROE of -0.19%. Regarding short-term risk, MSPR is more volatile compared to SLGCW. This indicates higher risk in terms of short-term price fluctuations for MSPR.Check SLGCW's competition here
TruBridge, Inc. (NASDAQ: TBRG)
MSPR vs TBRG Comparison November 2026
MSP Recovery, Inc. (NASDAQ: MSPR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MSPR stands at 1.4K. In comparison, TBRG has a market cap of 393.6M. Regarding current trading prices, MSPR is priced at $0.00 on the NASDAQ, while TBRG trades at $26.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MSPR currently has a P/E ratio of N/A, whereas TBRG's P/E ratio is 9.37. In terms of profitability, MSPR's ROE is N/A, compared to TBRG's ROE of +0.02%. Regarding short-term risk, MSPR is more volatile compared to TBRG. This indicates higher risk in terms of short-term price fluctuations for MSPR.Check TBRG's competition here
MultiPlan Corporation (NYSE: MPLN)
MSPR vs MPLN Comparison November 2026
MSP Recovery, Inc. (NASDAQ: MSPR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MSPR stands at 1.4K. In comparison, MPLN has a market cap of 375M. Regarding current trading prices, MSPR is priced at $0.00 on the NASDAQ, while MPLN trades at $23.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MSPR currently has a P/E ratio of N/A, whereas MPLN's P/E ratio is -0.23. In terms of profitability, MSPR's ROE is N/A, compared to MPLN's ROE of +1.40%. Regarding short-term risk, MSPR is more volatile compared to MPLN. This indicates higher risk in terms of short-term price fluctuations for MSPR.Check MPLN's competition here
Tabula Rasa HealthCare, Inc. (NASDAQ: TRHC)
MSPR vs TRHC Comparison November 2026
MSP Recovery, Inc. (NASDAQ: MSPR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MSPR stands at 1.4K. In comparison, TRHC has a market cap of 284M. Regarding current trading prices, MSPR is priced at $0.00 on the NASDAQ, while TRHC trades at $10.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MSPR currently has a P/E ratio of N/A, whereas TRHC's P/E ratio is -4.27. In terms of profitability, MSPR's ROE is N/A, compared to TRHC's ROE of +121.31%. Regarding short-term risk, MSPR is more volatile compared to TRHC. This indicates higher risk in terms of short-term price fluctuations for MSPR.Check TRHC's competition here
So-Young International Inc. (NASDAQ: SY)
MSPR vs SY Comparison November 2026
MSP Recovery, Inc. (NASDAQ: MSPR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MSPR stands at 1.4K. In comparison, SY has a market cap of 260.3M. Regarding current trading prices, MSPR is priced at $0.00 on the NASDAQ, while SY trades at $1.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MSPR currently has a P/E ratio of N/A, whereas SY's P/E ratio is -6.03. In terms of profitability, MSPR's ROE is N/A, compared to SY's ROE of -0.16%. Regarding short-term risk, MSPR is more volatile compared to SY. This indicates higher risk in terms of short-term price fluctuations for MSPR.Check SY's competition here
Spok Holdings, Inc. (NASDAQ: SPOK)
MSPR vs SPOK Comparison November 2026
MSP Recovery, Inc. (NASDAQ: MSPR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MSPR stands at 1.4K. In comparison, SPOK has a market cap of 250.2M. Regarding current trading prices, MSPR is priced at $0.00 on the NASDAQ, while SPOK trades at $11.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MSPR currently has a P/E ratio of N/A, whereas SPOK's P/E ratio is 13.46. In terms of profitability, MSPR's ROE is N/A, compared to SPOK's ROE of +0.13%. Regarding short-term risk, MSPR is more volatile compared to SPOK. This indicates higher risk in terms of short-term price fluctuations for MSPR.Check SPOK's competition here
Sema4 Holdings Corp. (NASDAQ: SMFR)
MSPR vs SMFR Comparison November 2026
MSP Recovery, Inc. (NASDAQ: MSPR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MSPR stands at 1.4K. In comparison, SMFR has a market cap of 246.4M. Regarding current trading prices, MSPR is priced at $0.00 on the NASDAQ, while SMFR trades at $0.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MSPR currently has a P/E ratio of N/A, whereas SMFR's P/E ratio is N/A. In terms of profitability, MSPR's ROE is N/A, compared to SMFR's ROE of -0.39%. Regarding short-term risk, MSPR is more volatile compared to SMFR. This indicates higher risk in terms of short-term price fluctuations for MSPR.Check SMFR's competition here
American Well Corporation (NYSE: AMWL)
MSPR vs AMWL Comparison November 2026
MSP Recovery, Inc. (NASDAQ: MSPR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MSPR stands at 1.4K. In comparison, AMWL has a market cap of 192M. Regarding current trading prices, MSPR is priced at $0.00 on the NASDAQ, while AMWL trades at $12.46.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MSPR currently has a P/E ratio of N/A, whereas AMWL's P/E ratio is -2.83. In terms of profitability, MSPR's ROE is N/A, compared to AMWL's ROE of -0.25%. Regarding short-term risk, MSPR is more volatile compared to AMWL. This indicates higher risk in terms of short-term price fluctuations for MSPR.Check AMWL's competition here
OptimizeRx Corp. (NASDAQ: OPRX)
MSPR vs OPRX Comparison November 2026
MSP Recovery, Inc. (NASDAQ: MSPR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MSPR stands at 1.4K. In comparison, OPRX has a market cap of 178.4M. Regarding current trading prices, MSPR is priced at $0.00 on the NASDAQ, while OPRX trades at $9.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MSPR currently has a P/E ratio of N/A, whereas OPRX's P/E ratio is 8.69. In terms of profitability, MSPR's ROE is N/A, compared to OPRX's ROE of +0.04%. Regarding short-term risk, MSPR is more volatile compared to OPRX. This indicates higher risk in terms of short-term price fluctuations for MSPR.Check OPRX's competition here
LifeMD, Inc. (NASDAQ: LFMDP)
MSPR vs LFMDP Comparison November 2026
MSP Recovery, Inc. (NASDAQ: MSPR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MSPR stands at 1.4K. In comparison, LFMDP has a market cap of 142.7M. Regarding current trading prices, MSPR is priced at $0.00 on the NASDAQ, while LFMDP trades at $20.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MSPR currently has a P/E ratio of N/A, whereas LFMDP's P/E ratio is -644.99. In terms of profitability, MSPR's ROE is N/A, compared to LFMDP's ROE of -1.79%. Regarding short-term risk, MSPR is more volatile compared to LFMDP. This indicates higher risk in terms of short-term price fluctuations for MSPR.Check LFMDP's competition here
Computer Programs and Systems, Inc. (NASDAQ: CPSI)
MSPR vs CPSI Comparison November 2026
MSP Recovery, Inc. (NASDAQ: MSPR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MSPR stands at 1.4K. In comparison, CPSI has a market cap of 133.7M. Regarding current trading prices, MSPR is priced at $0.00 on the NASDAQ, while CPSI trades at $9.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MSPR currently has a P/E ratio of N/A, whereas CPSI's P/E ratio is -183.80. In terms of profitability, MSPR's ROE is N/A, compared to CPSI's ROE of +0.02%. Regarding short-term risk, MSPR is more volatile compared to CPSI. This indicates higher risk in terms of short-term price fluctuations for MSPR.Check CPSI's competition here
Definitive Healthcare Corp. (NASDAQ: DH)
MSPR vs DH Comparison November 2026
MSP Recovery, Inc. (NASDAQ: MSPR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MSPR stands at 1.4K. In comparison, DH has a market cap of 120.1M. Regarding current trading prices, MSPR is priced at $0.00 on the NASDAQ, while DH trades at $1.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MSPR currently has a P/E ratio of N/A, whereas DH's P/E ratio is 4.33. In terms of profitability, MSPR's ROE is N/A, compared to DH's ROE of -0.83%. Regarding short-term risk, MSPR is more volatile compared to DH. This indicates higher risk in terms of short-term price fluctuations for MSPR.Check DH's competition here
Augmedix, Inc. (NASDAQ: AUGX)
MSPR vs AUGX Comparison November 2026
MSP Recovery, Inc. (NASDAQ: MSPR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MSPR stands at 1.4K. In comparison, AUGX has a market cap of 115.9M. Regarding current trading prices, MSPR is priced at $0.00 on the NASDAQ, while AUGX trades at $2.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MSPR currently has a P/E ratio of N/A, whereas AUGX's P/E ratio is -4.99. In terms of profitability, MSPR's ROE is N/A, compared to AUGX's ROE of -1.55%. Regarding short-term risk, MSPR is more volatile compared to AUGX. This indicates higher risk in terms of short-term price fluctuations for MSPR.Check AUGX's competition here
Health Catalyst, Inc. (NASDAQ: HCAT)
MSPR vs HCAT Comparison November 2026
MSP Recovery, Inc. (NASDAQ: MSPR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MSPR stands at 1.4K. In comparison, HCAT has a market cap of 114M. Regarding current trading prices, MSPR is priced at $0.00 on the NASDAQ, while HCAT trades at $1.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MSPR currently has a P/E ratio of N/A, whereas HCAT's P/E ratio is 7.57. In terms of profitability, MSPR's ROE is N/A, compared to HCAT's ROE of -1.28%. Regarding short-term risk, MSPR is more volatile compared to HCAT. This indicates higher risk in terms of short-term price fluctuations for MSPR.Check HCAT's competition here
CareCloud, Inc. (NASDAQ: CCLD)
MSPR vs CCLD Comparison November 2026
MSP Recovery, Inc. (NASDAQ: MSPR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MSPR stands at 1.4K. In comparison, CCLD has a market cap of 106.7M. Regarding current trading prices, MSPR is priced at $0.00 on the NASDAQ, while CCLD trades at $2.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MSPR currently has a P/E ratio of N/A, whereas CCLD's P/E ratio is 9.65. In terms of profitability, MSPR's ROE is N/A, compared to CCLD's ROE of +0.24%. Regarding short-term risk, MSPR is more volatile compared to CCLD. This indicates higher risk in terms of short-term price fluctuations for MSPR.Check CCLD's competition here
LifeMD, Inc. (NASDAQ: LFMD)
MSPR vs LFMD Comparison November 2026
MSP Recovery, Inc. (NASDAQ: MSPR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MSPR stands at 1.4K. In comparison, LFMD has a market cap of 101.1M. Regarding current trading prices, MSPR is priced at $0.00 on the NASDAQ, while LFMD trades at $2.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MSPR currently has a P/E ratio of N/A, whereas LFMD's P/E ratio is -4.19. In terms of profitability, MSPR's ROE is N/A, compared to LFMD's ROE of -1.79%. Regarding short-term risk, MSPR is more volatile compared to LFMD. This indicates higher risk in terms of short-term price fluctuations for MSPR.Check LFMD's competition here
Forian Inc. (NASDAQ: FORA)
MSPR vs FORA Comparison November 2026
MSP Recovery, Inc. (NASDAQ: MSPR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MSPR stands at 1.4K. In comparison, FORA has a market cap of 67.8M. Regarding current trading prices, MSPR is priced at $0.00 on the NASDAQ, while FORA trades at $2.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MSPR currently has a P/E ratio of N/A, whereas FORA's P/E ratio is -24.11. In terms of profitability, MSPR's ROE is N/A, compared to FORA's ROE of -0.17%. Regarding short-term risk, MSPR is more volatile compared to FORA. This indicates higher risk in terms of short-term price fluctuations for MSPR.Check FORA's competition here
CareCloud, Inc. (NASDAQ: CCLDP)
MSPR vs CCLDP Comparison November 2026
MSP Recovery, Inc. (NASDAQ: MSPR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MSPR stands at 1.4K. In comparison, CCLDP has a market cap of 59.9M. Regarding current trading prices, MSPR is priced at $0.00 on the NASDAQ, while CCLDP trades at $19.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MSPR currently has a P/E ratio of N/A, whereas CCLDP's P/E ratio is N/A. In terms of profitability, MSPR's ROE is N/A, compared to CCLDP's ROE of +0.24%. Regarding short-term risk, MSPR is more volatile compared to CCLDP. This indicates higher risk in terms of short-term price fluctuations for MSPR.Check CCLDP's competition here
OneMedNet Corporation (NASDAQ: ONMD)
MSPR vs ONMD Comparison November 2026
MSP Recovery, Inc. (NASDAQ: MSPR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MSPR stands at 1.4K. In comparison, ONMD has a market cap of 35.1M. Regarding current trading prices, MSPR is priced at $0.00 on the NASDAQ, while ONMD trades at $6.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MSPR currently has a P/E ratio of N/A, whereas ONMD's P/E ratio is -37.62. In terms of profitability, MSPR's ROE is N/A, compared to ONMD's ROE of +2.35%. Regarding short-term risk, MSPR is more volatile compared to ONMD. This indicates higher risk in terms of short-term price fluctuations for MSPR.Check ONMD's competition here
Science 37 Holdings, Inc. (NASDAQ: SNCE)
MSPR vs SNCE Comparison November 2026
MSP Recovery, Inc. (NASDAQ: MSPR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MSPR stands at 1.4K. In comparison, SNCE has a market cap of 34.7M. Regarding current trading prices, MSPR is priced at $0.00 on the NASDAQ, while SNCE trades at $5.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MSPR currently has a P/E ratio of N/A, whereas SNCE's P/E ratio is -0.27. In terms of profitability, MSPR's ROE is N/A, compared to SNCE's ROE of -0.47%. Regarding short-term risk, MSPR is more volatile compared to SNCE. This indicates higher risk in terms of short-term price fluctuations for MSPR.Check SNCE's competition here
Akili, Inc. (NASDAQ: AKLI)
MSPR vs AKLI Comparison November 2026
MSP Recovery, Inc. (NASDAQ: MSPR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MSPR stands at 1.4K. In comparison, AKLI has a market cap of 34.1M. Regarding current trading prices, MSPR is priced at $0.00 on the NASDAQ, while AKLI trades at $0.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MSPR currently has a P/E ratio of N/A, whereas AKLI's P/E ratio is -0.71. In terms of profitability, MSPR's ROE is N/A, compared to AKLI's ROE of -0.70%. Regarding short-term risk, MSPR is more volatile compared to AKLI. This indicates higher risk in terms of short-term price fluctuations for MSPR.Check AKLI's competition here
SHL Telemedicine Ltd. (NASDAQ: SHLT)
MSPR vs SHLT Comparison November 2026
MSP Recovery, Inc. (NASDAQ: MSPR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MSPR stands at 1.4K. In comparison, SHLT has a market cap of 33.6M. Regarding current trading prices, MSPR is priced at $0.00 on the NASDAQ, while SHLT trades at $2.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MSPR currently has a P/E ratio of N/A, whereas SHLT's P/E ratio is -3.87. In terms of profitability, MSPR's ROE is N/A, compared to SHLT's ROE of -0.50%. Regarding short-term risk, MSPR is more volatile compared to SHLT. This indicates higher risk in terms of short-term price fluctuations for MSPR.Check SHLT's competition here
Sharecare, Inc. (NASDAQ: SHCRW)
MSPR vs SHCRW Comparison November 2026
MSP Recovery, Inc. (NASDAQ: MSPR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MSPR stands at 1.4K. In comparison, SHCRW has a market cap of 32.5M. Regarding current trading prices, MSPR is priced at $0.00 on the NASDAQ, while SHCRW trades at $0.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MSPR currently has a P/E ratio of N/A, whereas SHCRW's P/E ratio is -0.00. In terms of profitability, MSPR's ROE is N/A, compared to SHCRW's ROE of -0.25%. Regarding short-term risk, MSPR is more volatile compared to SHCRW. This indicates higher risk in terms of short-term price fluctuations for MSPR.Check SHCRW's competition here
Streamline Health Solutions, Inc. (NASDAQ: STRM)
MSPR vs STRM Comparison November 2026
MSP Recovery, Inc. (NASDAQ: MSPR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MSPR stands at 1.4K. In comparison, STRM has a market cap of 23.2M. Regarding current trading prices, MSPR is priced at $0.00 on the NASDAQ, while STRM trades at $5.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MSPR currently has a P/E ratio of N/A, whereas STRM's P/E ratio is -2.40. In terms of profitability, MSPR's ROE is N/A, compared to STRM's ROE of -0.65%. Regarding short-term risk, MSPR is more volatile compared to STRM. This indicates higher risk in terms of short-term price fluctuations for MSPR.Check STRM's competition here
Renalytix Plc (NASDAQ: RNLX)
MSPR vs RNLX Comparison November 2026
MSP Recovery, Inc. (NASDAQ: MSPR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MSPR stands at 1.4K. In comparison, RNLX has a market cap of 22.5M. Regarding current trading prices, MSPR is priced at $0.00 on the NASDAQ, while RNLX trades at $0.21.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MSPR currently has a P/E ratio of N/A, whereas RNLX's P/E ratio is -0.33. In terms of profitability, MSPR's ROE is N/A, compared to RNLX's ROE of -6.31%. Regarding short-term risk, MSPR is more volatile compared to RNLX. This indicates higher risk in terms of short-term price fluctuations for MSPR.Check RNLX's competition here
MSP Recovery, Inc. (NASDAQ: LIFW)
MSPR vs LIFW Comparison November 2026
MSP Recovery, Inc. (NASDAQ: MSPR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MSPR stands at 1.4K. In comparison, LIFW has a market cap of 22.4M. Regarding current trading prices, MSPR is priced at $0.00 on the NASDAQ, while LIFW trades at $3.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MSPR currently has a P/E ratio of N/A, whereas LIFW's P/E ratio is -0.02. In terms of profitability, MSPR's ROE is N/A, compared to LIFW's ROE of +0.81%. Regarding short-term risk, MSPR is more volatile compared to LIFW. This indicates higher risk in terms of short-term price fluctuations for MSPR.Check LIFW's competition here
SCWorx Corp. (NASDAQ: WORX)
MSPR vs WORX Comparison November 2026
MSP Recovery, Inc. (NASDAQ: MSPR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MSPR stands at 1.4K. In comparison, WORX has a market cap of 21.9M. Regarding current trading prices, MSPR is priced at $0.00 on the NASDAQ, while WORX trades at $1.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MSPR currently has a P/E ratio of N/A, whereas WORX's P/E ratio is -1.59. In terms of profitability, MSPR's ROE is N/A, compared to WORX's ROE of -0.35%. Regarding short-term risk, MSPR is more volatile compared to WORX. This indicates higher risk in terms of short-term price fluctuations for MSPR.Check WORX's competition here
Babylon Holdings Limited (NYSE: BBLN)
MSPR vs BBLN Comparison November 2026
MSP Recovery, Inc. (NASDAQ: MSPR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MSPR stands at 1.4K. In comparison, BBLN has a market cap of 14.1M. Regarding current trading prices, MSPR is priced at $0.00 on the NASDAQ, while BBLN trades at $0.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MSPR currently has a P/E ratio of N/A, whereas BBLN's P/E ratio is -0.04. In terms of profitability, MSPR's ROE is N/A, compared to BBLN's ROE of +4.89%. Regarding short-term risk, MSPR is more volatile compared to BBLN. This indicates higher risk in terms of short-term price fluctuations for MSPR.Check BBLN's competition here
OneMedNet Corporation (NASDAQ: ONMDW)
MSPR vs ONMDW Comparison November 2026
MSP Recovery, Inc. (NASDAQ: MSPR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MSPR stands at 1.4K. In comparison, ONMDW has a market cap of 13.7M. Regarding current trading prices, MSPR is priced at $0.00 on the NASDAQ, while ONMDW trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MSPR currently has a P/E ratio of N/A, whereas ONMDW's P/E ratio is -0.09. In terms of profitability, MSPR's ROE is N/A, compared to ONMDW's ROE of +2.35%. Regarding short-term risk, MSPR is more volatile compared to ONMDW. This indicates higher risk in terms of short-term price fluctuations for MSPR.Check ONMDW's competition here
Bullfrog AI Holdings, Inc. Common Stock (NASDAQ: BFRG)
MSPR vs BFRG Comparison November 2026
MSP Recovery, Inc. (NASDAQ: MSPR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MSPR stands at 1.4K. In comparison, BFRG has a market cap of 10.3M. Regarding current trading prices, MSPR is priced at $0.00 on the NASDAQ, while BFRG trades at $0.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MSPR currently has a P/E ratio of N/A, whereas BFRG's P/E ratio is -1.21. In terms of profitability, MSPR's ROE is N/A, compared to BFRG's ROE of -1.50%. Regarding short-term risk, MSPR is more volatile compared to BFRG. This indicates higher risk in terms of short-term price fluctuations for MSPR.Check BFRG's competition here
ETAO International Co., Ltd. (NASDAQ: ETAO)
MSPR vs ETAO Comparison November 2026
MSP Recovery, Inc. (NASDAQ: MSPR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MSPR stands at 1.4K. In comparison, ETAO has a market cap of 9.8M. Regarding current trading prices, MSPR is priced at $0.00 on the NASDAQ, while ETAO trades at $1.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MSPR currently has a P/E ratio of N/A, whereas ETAO's P/E ratio is -0.01. In terms of profitability, MSPR's ROE is N/A, compared to ETAO's ROE of -13.69%. Regarding short-term risk, MSPR is more volatile compared to ETAO. This indicates higher risk in terms of short-term price fluctuations for MSPR.Check ETAO's competition here
UpHealth, Inc. (NYSE: UPH-WT)
MSPR vs UPH-WT Comparison November 2026
MSP Recovery, Inc. (NASDAQ: MSPR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MSPR stands at 1.4K. In comparison, UPH-WT has a market cap of 5.3M. Regarding current trading prices, MSPR is priced at $0.00 on the NASDAQ, while UPH-WT trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MSPR currently has a P/E ratio of N/A, whereas UPH-WT's P/E ratio is N/A. In terms of profitability, MSPR's ROE is N/A, compared to UPH-WT's ROE of -0.72%. Regarding short-term risk, MSPR is more volatile compared to UPH-WT. This indicates higher risk in terms of short-term price fluctuations for MSPR.Check UPH-WT's competition here
UpHealth, Inc. (NYSE: UPH)
MSPR vs UPH Comparison November 2026
MSP Recovery, Inc. (NASDAQ: MSPR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MSPR stands at 1.4K. In comparison, UPH has a market cap of 5.3M. Regarding current trading prices, MSPR is priced at $0.00 on the NASDAQ, while UPH trades at $0.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MSPR currently has a P/E ratio of N/A, whereas UPH's P/E ratio is -0.07. In terms of profitability, MSPR's ROE is N/A, compared to UPH's ROE of -1.05%. Regarding short-term risk, MSPR is more volatile compared to UPH. This indicates higher risk in terms of short-term price fluctuations for MSPR.Check UPH's competition here
Aclarion, Inc. (NASDAQ: ACON)
MSPR vs ACON Comparison November 2026
MSP Recovery, Inc. (NASDAQ: MSPR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MSPR stands at 1.4K. In comparison, ACON has a market cap of 5.1M. Regarding current trading prices, MSPR is priced at $0.00 on the NASDAQ, while ACON trades at $1.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MSPR currently has a P/E ratio of N/A, whereas ACON's P/E ratio is -0.20. In terms of profitability, MSPR's ROE is N/A, compared to ACON's ROE of -0.63%. Regarding short-term risk, MSPR is more volatile compared to ACON. This indicates higher risk in terms of short-term price fluctuations for MSPR.Check ACON's competition here
Mangoceuticals, Inc. (NASDAQ: MGRX)
MSPR vs MGRX Comparison November 2026
MSP Recovery, Inc. (NASDAQ: MSPR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MSPR stands at 1.4K. In comparison, MGRX has a market cap of 4.4M. Regarding current trading prices, MSPR is priced at $0.00 on the NASDAQ, while MGRX trades at $0.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MSPR currently has a P/E ratio of N/A, whereas MGRX's P/E ratio is -0.15. In terms of profitability, MSPR's ROE is N/A, compared to MGRX's ROE of -1.06%. Regarding short-term risk, MSPR is more volatile compared to MGRX. This indicates higher risk in terms of short-term price fluctuations for MSPR.Check MGRX's competition here
Pear Therapeutics, Inc. (NASDAQ: PEAR)
MSPR vs PEAR Comparison November 2026
MSP Recovery, Inc. (NASDAQ: MSPR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MSPR stands at 1.4K. In comparison, PEAR has a market cap of 4.1M. Regarding current trading prices, MSPR is priced at $0.00 on the NASDAQ, while PEAR trades at $0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MSPR currently has a P/E ratio of N/A, whereas PEAR's P/E ratio is -0.08. In terms of profitability, MSPR's ROE is N/A, compared to PEAR's ROE of -0.39%. Regarding short-term risk, MSPR is more volatile compared to PEAR. This indicates higher risk in terms of short-term price fluctuations for MSPR.Check PEAR's competition here
Pear Therapeutics, Inc. (NASDAQ: PEARW)
MSPR vs PEARW Comparison November 2026
MSP Recovery, Inc. (NASDAQ: MSPR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MSPR stands at 1.4K. In comparison, PEARW has a market cap of 4.1M. Regarding current trading prices, MSPR is priced at $0.00 on the NASDAQ, while PEARW trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MSPR currently has a P/E ratio of N/A, whereas PEARW's P/E ratio is -0.00. In terms of profitability, MSPR's ROE is N/A, compared to PEARW's ROE of -0.39%. Regarding short-term risk, MSPR is more volatile compared to PEARW. This indicates higher risk in terms of short-term price fluctuations for MSPR.Check PEARW's competition here
Healthcare Triangle, Inc. (NASDAQ: HCTI)
MSPR vs HCTI Comparison November 2026
MSP Recovery, Inc. (NASDAQ: MSPR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MSPR stands at 1.4K. In comparison, HCTI has a market cap of 3.2M. Regarding current trading prices, MSPR is priced at $0.00 on the NASDAQ, while HCTI trades at $4.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MSPR currently has a P/E ratio of N/A, whereas HCTI's P/E ratio is -0.54. In terms of profitability, MSPR's ROE is N/A, compared to HCTI's ROE of -0.56%. Regarding short-term risk, MSPR is more volatile compared to HCTI. This indicates higher risk in terms of short-term price fluctuations for MSPR.Check HCTI's competition here
Ontrak, Inc. (NASDAQ: OTRK)
MSPR vs OTRK Comparison November 2026
MSP Recovery, Inc. (NASDAQ: MSPR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MSPR stands at 1.4K. In comparison, OTRK has a market cap of 2.3M. Regarding current trading prices, MSPR is priced at $0.00 on the NASDAQ, while OTRK trades at $0.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MSPR currently has a P/E ratio of N/A, whereas OTRK's P/E ratio is -0.02. In terms of profitability, MSPR's ROE is N/A, compared to OTRK's ROE of -2.11%. Regarding short-term risk, MSPR is more volatile compared to OTRK. This indicates higher risk in terms of short-term price fluctuations for MSPR.Check OTRK's competition here
CareMax, Inc. (NASDAQ: CMAX)
MSPR vs CMAX Comparison November 2026
MSP Recovery, Inc. (NASDAQ: MSPR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MSPR stands at 1.4K. In comparison, CMAX has a market cap of 1.6M. Regarding current trading prices, MSPR is priced at $0.00 on the NASDAQ, while CMAX trades at $0.42.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MSPR currently has a P/E ratio of N/A, whereas CMAX's P/E ratio is -0.00. In terms of profitability, MSPR's ROE is N/A, compared to CMAX's ROE of -2.01%. Regarding short-term risk, MSPR is more volatile compared to CMAX. This indicates higher risk in terms of short-term price fluctuations for MSPR.Check CMAX's competition here
Bullfrog AI Holdings, Inc. Warrants (NASDAQ: BFRGW)
MSPR vs BFRGW Comparison November 2026
MSP Recovery, Inc. (NASDAQ: MSPR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MSPR stands at 1.4K. In comparison, BFRGW has a market cap of 1.4M. Regarding current trading prices, MSPR is priced at $0.00 on the NASDAQ, while BFRGW trades at $0.11.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MSPR currently has a P/E ratio of N/A, whereas BFRGW's P/E ratio is -0.23. In terms of profitability, MSPR's ROE is N/A, compared to BFRGW's ROE of -1.50%. Regarding short-term risk, MSPR is more volatile compared to BFRGW. This indicates higher risk in terms of short-term price fluctuations for MSPR.Check BFRGW's competition here
MSP Recovery, Inc. (NASDAQ: LIFWZ)
MSPR vs LIFWZ Comparison November 2026
MSP Recovery, Inc. (NASDAQ: MSPR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MSPR stands at 1.4K. In comparison, LIFWZ has a market cap of 1.3M. Regarding current trading prices, MSPR is priced at $0.00 on the NASDAQ, while LIFWZ trades at $0.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MSPR currently has a P/E ratio of N/A, whereas LIFWZ's P/E ratio is N/A. In terms of profitability, MSPR's ROE is N/A, compared to LIFWZ's ROE of +0.81%. Regarding short-term risk, MSPR is more volatile compared to LIFWZ. This indicates higher risk in terms of short-term price fluctuations for MSPR.Check LIFWZ's competition here
VSee Health, Inc. (NASDAQ: VSEE)
MSPR vs VSEE Comparison November 2026
MSP Recovery, Inc. (NASDAQ: MSPR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MSPR stands at 1.4K. In comparison, VSEE has a market cap of 701.3K. Regarding current trading prices, MSPR is priced at $0.00 on the NASDAQ, while VSEE trades at $0.87.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MSPR currently has a P/E ratio of N/A, whereas VSEE's P/E ratio is -1.94. In terms of profitability, MSPR's ROE is N/A, compared to VSEE's ROE of -4.01%. Regarding short-term risk, MSPR is more volatile compared to VSEE. This indicates higher risk in terms of short-term price fluctuations for MSPR.Check VSEE's competition here
VSee Health, Inc. (NASDAQ: VSEEW)
MSPR vs VSEEW Comparison November 2026
MSP Recovery, Inc. (NASDAQ: MSPR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MSPR stands at 1.4K. In comparison, VSEEW has a market cap of 560.3K. Regarding current trading prices, MSPR is priced at $0.00 on the NASDAQ, while VSEEW trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MSPR currently has a P/E ratio of N/A, whereas VSEEW's P/E ratio is -0.04. In terms of profitability, MSPR's ROE is N/A, compared to VSEEW's ROE of -4.01%. Regarding short-term risk, MSPR is more volatile compared to VSEEW. This indicates higher risk in terms of short-term price fluctuations for MSPR.Check VSEEW's competition here
MSP Recovery, Inc. (NASDAQ: MSPRZ)
MSPR vs MSPRZ Comparison November 2026
MSP Recovery, Inc. (NASDAQ: MSPR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MSPR stands at 1.4K. In comparison, MSPRZ has a market cap of 550.4K. Regarding current trading prices, MSPR is priced at $0.00 on the NASDAQ, while MSPRZ trades at $0.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MSPR currently has a P/E ratio of N/A, whereas MSPRZ's P/E ratio is N/A. In terms of profitability, MSPR's ROE is N/A, compared to MSPRZ's ROE of +0.81%. Regarding short-term risk, MSPR is more volatile compared to MSPRZ. This indicates higher risk in terms of short-term price fluctuations for MSPR.Check MSPRZ's competition here
Akerna Corp. (NASDAQ: KERNW)
MSPR vs KERNW Comparison November 2026
MSP Recovery, Inc. (NASDAQ: MSPR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MSPR stands at 1.4K. In comparison, KERNW has a market cap of 162.3K. Regarding current trading prices, MSPR is priced at $0.00 on the NASDAQ, while KERNW trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MSPR currently has a P/E ratio of N/A, whereas KERNW's P/E ratio is -0.00. In terms of profitability, MSPR's ROE is N/A, compared to KERNW's ROE of -0.02%. Regarding short-term risk, MSPR is more volatile compared to KERNW. This indicates higher risk in terms of short-term price fluctuations for MSPR.Check KERNW's competition here
Akerna Corp. (NASDAQ: KERN)
MSPR vs KERN Comparison November 2026
MSP Recovery, Inc. (NASDAQ: MSPR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MSPR stands at 1.4K. In comparison, KERN has a market cap of 162.3K. Regarding current trading prices, MSPR is priced at $0.00 on the NASDAQ, while KERN trades at $0.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MSPR currently has a P/E ratio of N/A, whereas KERN's P/E ratio is -0.01. In terms of profitability, MSPR's ROE is N/A, compared to KERN's ROE of -0.02%. Regarding short-term risk, MSPR is more volatile compared to KERN. This indicates higher risk in terms of short-term price fluctuations for MSPR.Check KERN's competition here
MSP Recovery, Inc. (NASDAQ: LIFWW)
MSPR vs LIFWW Comparison November 2026
MSP Recovery, Inc. (NASDAQ: MSPR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MSPR stands at 1.4K. In comparison, LIFWW has a market cap of 60.1K. Regarding current trading prices, MSPR is priced at $0.00 on the NASDAQ, while LIFWW trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MSPR currently has a P/E ratio of N/A, whereas LIFWW's P/E ratio is N/A. In terms of profitability, MSPR's ROE is N/A, compared to LIFWW's ROE of +0.81%. Regarding short-term risk, MSPR is more volatile compared to LIFWW. This indicates higher risk in terms of short-term price fluctuations for MSPR.Check LIFWW's competition here
CareMax, Inc. (NASDAQ: CMAXW)
MSPR vs CMAXW Comparison November 2026
MSP Recovery, Inc. (NASDAQ: MSPR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MSPR stands at 1.4K. In comparison, CMAXW has a market cap of 36.4K. Regarding current trading prices, MSPR is priced at $0.00 on the NASDAQ, while CMAXW trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MSPR currently has a P/E ratio of N/A, whereas CMAXW's P/E ratio is N/A. In terms of profitability, MSPR's ROE is N/A, compared to CMAXW's ROE of -2.01%. Regarding short-term risk, MSPR is more volatile compared to CMAXW. This indicates higher risk in terms of short-term price fluctuations for MSPR.Check CMAXW's competition here
Zhongchao Inc. (NASDAQ: ZCMD)
MSPR vs ZCMD Comparison November 2026
MSP Recovery, Inc. (NASDAQ: MSPR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MSPR stands at 1.4K. In comparison, ZCMD has a market cap of 16.7K. Regarding current trading prices, MSPR is priced at $0.00 on the NASDAQ, while ZCMD trades at $1.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MSPR currently has a P/E ratio of N/A, whereas ZCMD's P/E ratio is -0.03. In terms of profitability, MSPR's ROE is N/A, compared to ZCMD's ROE of -0.54%. Regarding short-term risk, MSPR is more volatile compared to ZCMD. This indicates higher risk in terms of short-term price fluctuations for MSPR.Check ZCMD's competition here
Aclarion, Inc. (NASDAQ: ACONW)
MSPR vs ACONW Comparison November 2026
MSP Recovery, Inc. (NASDAQ: MSPR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MSPR stands at 1.4K. In comparison, ACONW has a market cap of 14.3K. Regarding current trading prices, MSPR is priced at $0.00 on the NASDAQ, while ACONW trades at $0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MSPR currently has a P/E ratio of N/A, whereas ACONW's P/E ratio is N/A. In terms of profitability, MSPR's ROE is N/A, compared to ACONW's ROE of -0.63%. Regarding short-term risk, MSPR is more volatile compared to ACONW. This indicates higher risk in terms of short-term price fluctuations for MSPR.Check ACONW's competition here
MSP Recovery, Inc. (NASDAQ: MSPRV)
MSPR vs MSPRV Comparison November 2026
MSP Recovery, Inc. (NASDAQ: MSPR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MSPR stands at 1.4K. In comparison, MSPRV has a market cap of 0. Regarding current trading prices, MSPR is priced at $0.00 on the NASDAQ, while MSPRV trades at $0.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MSPR currently has a P/E ratio of N/A, whereas MSPRV's P/E ratio is N/A. In terms of profitability, MSPR's ROE is N/A, compared to MSPRV's ROE of N/A. Regarding short-term risk, MSPR is more volatile compared to MSPRV. This indicates higher risk in terms of short-term price fluctuations for MSPR.Check MSPRV's competition here
CareCloud, Inc. (NASDAQ: MTBC)
MSPR vs MTBC Comparison November 2026
MSP Recovery, Inc. (NASDAQ: MSPR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MSPR stands at 1.4K. In comparison, MTBC has a market cap of 0. Regarding current trading prices, MSPR is priced at $0.00 on the NASDAQ, while MTBC trades at $3.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MSPR currently has a P/E ratio of N/A, whereas MTBC's P/E ratio is N/A. In terms of profitability, MSPR's ROE is N/A, compared to MTBC's ROE of +0.30%. Regarding short-term risk, MSPR is more volatile compared to MTBC. This indicates higher risk in terms of short-term price fluctuations for MSPR.Check MTBC's competition here
CareCloud, Inc. (NASDAQ: MTBCP)
MSPR vs MTBCP Comparison November 2026
MSP Recovery, Inc. (NASDAQ: MSPR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MSPR stands at 1.4K. In comparison, MTBCP has a market cap of 0. Regarding current trading prices, MSPR is priced at $0.00 on the NASDAQ, while MTBCP trades at $26.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MSPR currently has a P/E ratio of N/A, whereas MTBCP's P/E ratio is N/A. In terms of profitability, MSPR's ROE is N/A, compared to MTBCP's ROE of +0.24%. Regarding short-term risk, MSPR is more volatile compared to MTBCP. This indicates higher risk in terms of short-term price fluctuations for MSPR.Check MTBCP's competition here
Nava Health MD, LLC (NASDAQ: NAVA)
MSPR vs NAVA Comparison November 2026
MSP Recovery, Inc. (NASDAQ: MSPR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MSPR stands at 1.4K. In comparison, NAVA has a market cap of 0. Regarding current trading prices, MSPR is priced at $0.00 on the NASDAQ, while NAVA trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MSPR currently has a P/E ratio of N/A, whereas NAVA's P/E ratio is N/A. In terms of profitability, MSPR's ROE is N/A, compared to NAVA's ROE of +0.15%. Regarding short-term risk, MSPR is not fully comparable compared to NAVA. This indicates unavailable risk data in terms of short-term price fluctuations for MSPR.Check NAVA's competition here
Affymetrix, Inc. (NASDAQ: AFFX)
MSPR vs AFFX Comparison November 2026
MSP Recovery, Inc. (NASDAQ: MSPR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MSPR stands at 1.4K. In comparison, AFFX has a market cap of 0. Regarding current trading prices, MSPR is priced at $0.00 on the NASDAQ, while AFFX trades at $14.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MSPR currently has a P/E ratio of N/A, whereas AFFX's P/E ratio is N/A. In terms of profitability, MSPR's ROE is N/A, compared to AFFX's ROE of +0.03%. Regarding short-term risk, MSPR is more volatile compared to AFFX. This indicates higher risk in terms of short-term price fluctuations for MSPR.Check AFFX's competition here
Change Healthcare Inc. (NASDAQ: CHNGU)
MSPR vs CHNGU Comparison November 2026
MSP Recovery, Inc. (NASDAQ: MSPR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MSPR stands at 1.4K. In comparison, CHNGU has a market cap of 0. Regarding current trading prices, MSPR is priced at $0.00 on the NASDAQ, while CHNGU trades at $73.71.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MSPR currently has a P/E ratio of N/A, whereas CHNGU's P/E ratio is N/A. In terms of profitability, MSPR's ROE is N/A, compared to CHNGU's ROE of -0.05%. Regarding short-term risk, MSPR is more volatile compared to CHNGU. This indicates higher risk in terms of short-term price fluctuations for MSPR.Check CHNGU's competition here
Alkuri Global Acquisition Corp. (NASDAQ: KURIU)
MSPR vs KURIU Comparison November 2026
MSP Recovery, Inc. (NASDAQ: MSPR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MSPR stands at 1.4K. In comparison, KURIU has a market cap of 0. Regarding current trading prices, MSPR is priced at $0.00 on the NASDAQ, while KURIU trades at $9.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MSPR currently has a P/E ratio of N/A, whereas KURIU's P/E ratio is N/A. In terms of profitability, MSPR's ROE is N/A, compared to KURIU's ROE of +1.06%. Regarding short-term risk, MSPR is more volatile compared to KURIU. This indicates higher risk in terms of short-term price fluctuations for MSPR.Check KURIU's competition here
Cerner Corporation (NASDAQ: CERN)
MSPR vs CERN Comparison November 2026
MSP Recovery, Inc. (NASDAQ: MSPR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MSPR stands at 1.4K. In comparison, CERN has a market cap of 0. Regarding current trading prices, MSPR is priced at $0.00 on the NASDAQ, while CERN trades at $94.92.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MSPR currently has a P/E ratio of N/A, whereas CERN's P/E ratio is 55.84. In terms of profitability, MSPR's ROE is N/A, compared to CERN's ROE of +0.14%. Regarding short-term risk, MSPR is more volatile compared to CERN. This indicates higher risk in terms of short-term price fluctuations for MSPR.Check CERN's competition here
Change Healthcare Inc. (NASDAQ: CHNG)
MSPR vs CHNG Comparison November 2026
MSP Recovery, Inc. (NASDAQ: MSPR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MSPR stands at 1.4K. In comparison, CHNG has a market cap of 0. Regarding current trading prices, MSPR is priced at $0.00 on the NASDAQ, while CHNG trades at $27.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MSPR currently has a P/E ratio of N/A, whereas CHNG's P/E ratio is -152.72. In terms of profitability, MSPR's ROE is N/A, compared to CHNG's ROE of -0.05%. Regarding short-term risk, MSPR is more volatile compared to CHNG. This indicates higher risk in terms of short-term price fluctuations for MSPR.Check CHNG's competition here
Castlight Health, Inc. (NYSE: CSLT)
MSPR vs CSLT Comparison November 2026
MSP Recovery, Inc. (NASDAQ: MSPR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MSPR stands at 1.4K. In comparison, CSLT has a market cap of 0. Regarding current trading prices, MSPR is priced at $0.00 on the NASDAQ, while CSLT trades at $2.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MSPR currently has a P/E ratio of N/A, whereas CSLT's P/E ratio is -37.27. In terms of profitability, MSPR's ROE is N/A, compared to CSLT's ROE of -0.42%. Regarding short-term risk, MSPR is more volatile compared to CSLT. This indicates higher risk in terms of short-term price fluctuations for MSPR.Check CSLT's competition here
IMS Health Holdings, Inc. (NYSE: IMS)
MSPR vs IMS Comparison November 2026
MSP Recovery, Inc. (NASDAQ: MSPR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MSPR stands at 1.4K. In comparison, IMS has a market cap of 0. Regarding current trading prices, MSPR is priced at $0.00 on the NASDAQ, while IMS trades at $31.34.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MSPR currently has a P/E ratio of N/A, whereas IMS's P/E ratio is N/A. In terms of profitability, MSPR's ROE is N/A, compared to IMS's ROE of +0.27%. Regarding short-term risk, MSPR is more volatile compared to IMS. This indicates higher risk in terms of short-term price fluctuations for MSPR.Check IMS's competition here
CareCloud, Inc. (NASDAQ: MTBCO)
MSPR vs MTBCO Comparison November 2026
MSP Recovery, Inc. (NASDAQ: MSPR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MSPR stands at 1.4K. In comparison, MTBCO has a market cap of 0. Regarding current trading prices, MSPR is priced at $0.00 on the NASDAQ, while MTBCO trades at $25.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MSPR currently has a P/E ratio of N/A, whereas MTBCO's P/E ratio is N/A. In terms of profitability, MSPR's ROE is N/A, compared to MTBCO's ROE of +0.24%. Regarding short-term risk, MSPR is more volatile compared to MTBCO. This indicates higher risk in terms of short-term price fluctuations for MSPR.Check MTBCO's competition here
Sema4 Holdings Corp. (NASDAQ: SMFRW)
MSPR vs SMFRW Comparison November 2026
MSP Recovery, Inc. (NASDAQ: MSPR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MSPR stands at 1.4K. In comparison, SMFRW has a market cap of 0. Regarding current trading prices, MSPR is priced at $0.00 on the NASDAQ, while SMFRW trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MSPR currently has a P/E ratio of N/A, whereas SMFRW's P/E ratio is N/A. In terms of profitability, MSPR's ROE is N/A, compared to SMFRW's ROE of -0.39%. Regarding short-term risk, MSPR is more volatile compared to SMFRW. This indicates higher risk in terms of short-term price fluctuations for MSPR.Check SMFRW's competition here
NantHealth, Inc. (NASDAQ: NH)
MSPR vs NH Comparison November 2026
MSP Recovery, Inc. (NASDAQ: MSPR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MSPR stands at 1.4K. In comparison, NH has a market cap of 0. Regarding current trading prices, MSPR is priced at $0.00 on the NASDAQ, while NH trades at $1.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MSPR currently has a P/E ratio of N/A, whereas NH's P/E ratio is -0.12. In terms of profitability, MSPR's ROE is N/A, compared to NH's ROE of +0.35%. Regarding short-term risk, MSPR is more volatile compared to NH. This indicates higher risk in terms of short-term price fluctuations for MSPR.Check NH's competition here
Convey Health Solutions Holdings, Inc. (NYSE: CNVY)
MSPR vs CNVY Comparison November 2026
MSP Recovery, Inc. (NASDAQ: MSPR) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MSPR stands at 1.4K. In comparison, CNVY has a market cap of 0. Regarding current trading prices, MSPR is priced at $0.00 on the NASDAQ, while CNVY trades at $10.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MSPR currently has a P/E ratio of N/A, whereas CNVY's P/E ratio is -71.50. In terms of profitability, MSPR's ROE is N/A, compared to CNVY's ROE of -0.02%. Regarding short-term risk, MSPR is more volatile compared to CNVY. This indicates higher risk in terms of short-term price fluctuations for MSPR.Check CNVY's competition here